A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Clinical trial NCT05583838 · COMPLETED

Trial details

NCT number: NCT05583838
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Previously Treated Primary Immune Thrombocytopenia

Start date: 2022-11-22
Primary completion: 2024-02-28
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.